RxDoctor Payments Data

Nicole Williamson

Family · Cleveland, OHNPI 1164966222

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.0% of the total across 152 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,958 and has fallen 90.5% since, to $186 in 2025. Among family clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,797in general payments, 2019–2025

Across 152 payments — averaging $24.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$800
  • Sanofi$423
  • LEO Pharma Inc.$329
  • Lilly USA, LLC$323
  • E.r. Squibb & Sons, L.L.C.$290
  • Regeneron Healthcare Solutions, Inc.$222
  • plus $1K from 13 others

What the payments were for

  • Food & beverage$3,60795%
  • Education$1905%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,797 in reported general payments places this provider in the 90th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio →

Medicare billing

Part B allowed, 2024
$4,160
Medicare patients
49
Services billed
93

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab15$62,937
Clobetasol Propionate91$3,918
Ketoconazole115$2,468
Azelaic Acid12$2,173
Tretinoin24$1,836
Metronidazole14$1,610
Clindamycin Phosphate44$1,497
Desonide19$1,262
Triamcinolone Acetonide80$931
Ammonium Lactate40$736
Ciclopirox13$409
Minoxidil12$198
Hydrocortisone28$140
Spironolactone13$136
Mupirocin11$39

Paid to pharmacies, not to this prescriber.

Other family in Cleveland

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →